Inside Matters

Dr James McIlroy
Inside Matters
Latest episode

70 episodes

  • Inside Matters

    The Importance of the Reproductive Tract Microbiome: Insights from David MacIntyre

    02/04/2026 | 1h 18 mins.
    For years, the spotlight in microbiome research has been firmly on the gut. We’ve learned that diversity there is generally a good thing—linked to resilience, health, and better outcomes.

    But what if one of the most important microbiomes in the body follows completely different rules?

    In a recent conversation, Dr James McIlroy sat down with Professor David MacIntyre, Director of the Robinson Research Institute, to explore a rapidly emerging field: the female reproductive tract microbiome.

    What they uncovered challenges many assumptions—and could transform how we think about pregnancy, birth, and early life health.

     

    00:00 Show Returns
    01:34 Why Reproductive Microbiome
    05:15 Low Diversity Health
    09:24 Lactobacillus Protection
    12:06 Human Uniqueness
    14:17 Population Differences
    16:31 Oral Probiotics Myth
    19:25 Vaginal Biotherapeutics Trial
    22:11 Host Immune Response
    27:03 Dysbiosis Triggers
    30:42 Microbiome and Preterm Birth
    33:06 Labor Inflammation Pathways
    38:10 Pregnancy Microbiome Shifts
    39:11 Screening and Group B Strep
    40:57 Microbiome Screening Potential
    42:06 Global Data Predictive Signatures
    43:23 Limits of Current Risk Tools
    45:30 Point of Care Profiling Vision
    46:50 Swab Mass Spec Barcoding
    48:27 Composition Versus Host Response
    49:58 Metabolic Dark Matter
    52:13 Beyond Bacteria, Viruses, and Fungi
    55:48 Vaginal Probiotic Trials
    57:39 Phase Two Trial Endpoints
    01:01:28 Vaginal Microbiome Transplants
    01:05:46 Birth Seeding After C Section
    01:10:57 Do Vaginal Strains Persist
    01:14:05 Ten-Year Personalised Medicine
    01:17:45 Wrap Up And Where To Find

     

    A Different Kind of Microbiome
    When we talk about the gut microbiome, diversity is often considered a hallmark of health.

    The reproductive tract? It’s the opposite.

    In healthy women, this environment is typically:

    Low in diversity

    Dominated by one key group of bacteria: Lactobacillus

    This might sound counterintuitive—but it’s by design.

    Why low diversity works here
    Certain Lactobacillus species—particularly Lactobacillus crispatus—play a protective role by:

    Producing lactic acid, keeping the environment acidic (around pH 4)

    Preventing harmful microbes from growing

    Blocking pathogens from attaching to tissue

    Producing antimicrobial compounds

    In short, they create a stable, protective ecosystem.

    When this balance is disrupted and diversity increases, it’s often linked to:

    Infection

    Inflammation

    Poor reproductive outcomes

    A Unique Human Feature
    One of the most surprising insights?

    Humans are the only species known to have a Lactobacillus-dominated reproductive microbiome.

    Even our closest primate relatives don’t share this feature.

    That suggests this system evolved relatively recently—and likely offers a meaningful biological advantage, particularly in pregnancy and childbirth.

    The Link to Preterm Birth
    Preterm birth—defined as delivery before 37 weeks—affects around 1 in 10 pregnancies globally and remains a major medical challenge.

    The microbiome appears to play a key role, particularly in early preterm births.

    What’s happening biologically?

    In a healthy pregnancy, labour is triggered by controlled, sterile inflammation

    This process helps:

    Break the membranes (waters)

    Open the cervix

    Initiate contractions

    But if inflammation starts too early, it can trigger premature labour.

    Where the microbiome fits in
    A Lactobacillus-dominant microbiome helps:

    Keep inflammation low

    Maintain a strong mucosal barrier

    Reduce infection risk

    When this balance is lost:

    The environment becomes less acidic

    Inflammatory molecules increase

    The barrier weakens

    Risk of infection—and preterm labour—rises

    Once inflammation starts, it’s very difficult to switch off.

    That’s why prevention is so important.

    What Disrupts the Balance?
    Several factors can shift the microbiome away from its protective state:

    Antibiotics (even when used for unrelated infections)

    Sexual transmission of bacteria

    Hormonal changes

    Menstruation

    Hygiene practices like douching

    Even small changes in pH or environment can allow harmful bacteria to gain a foothold.

    Can We Predict Risk Earlier?
    One of the most exciting areas of research is using the microbiome as a predictive tool.

    Scientists are working towards:

    Identifying microbial “signatures” linked to higher risk

    Measuring both:

    Which microbes are present

    How the body is responding to them

    New technologies can now analyse a simple swab and generate a metabolic “barcode” in minutes—potentially enabling rapid screening.

    The long-term vision?
    Routine testing that identifies at-risk pregnancies early—before symptoms appear.

    Can We Change the Microbiome?
    If we can measure it, can we fix it?

    1. Oral probiotics: limited impact
    Despite widespread marketing, there’s little evidence that oral probiotics reliably reach or colonise the reproductive tract.

    They may have indirect benefits—but they’re not an efficient delivery method.

    2. Targeted vaginal probiotics
    More promising is direct delivery of beneficial bacteria.

    A recent clinical trial explored a vaginally delivered strain of Lactobacillus crispatus:

    Safe and well tolerated in pregnancy

    Successfully colonised the microbiome

    Showed early signs of reducing preterm birth risk

    A larger, definitive trial is now underway in the UK.

    3. Microbiome transplantation
    Inspired by faecal transplants, researchers are exploring vaginal microbiome transplants.

    Early studies show potential—but challenges remain:

    Regulation

    Standardisation

    Safety at scale

    For now, this remains experimental.

    The First Microbial Gift: Birth
    The microbiome’s role doesn’t stop at pregnancy.

    During vaginal birth, babies are exposed to their mother’s microbes—an important early “seeding” event.

    Babies born via caesarean section:

    Have different early microbiomes

    May face higher risks of certain conditions (e.g. allergies)

    There’s growing interest in “vaginal seeding” for C-section babies—but:

    Evidence is still emerging

    Safety concerns remain

    It’s not yet standard practice

    A Shift Towards Personalised Pregnancy Care
    Looking ahead, this field is moving towards a precision medicine approach.

    Instead of treating all pregnancies the same, we may soon:

    Assess individual microbiome profiles

    Measure immune responses

    Identify personalised risk

    Apply targeted interventions early—or even before conception

    The goal?

    Not just preventing complications—but optimising pregnancy from the start.

    Why This Matters
    This isn’t just about microbes—it’s about long-term health.

    By improving the maternal microbiome, we may:

    Reduce preterm birth

    Improve newborn outcomes

    Influence lifelong health trajectories

    As Professor MacIntyre puts it, we’re on the cusp of a major shift—from reacting to problems to preventing them before they begin.
  • Inside Matters

    Gut Health, Celiac Disease & the Future of Microbiome Medicine — With Dr Debra Silberg

    04/12/2025 | 59 mins.
    Dr Debra Silberg joins Inside Matters for a deep, wide-ranging conversation on gut health, drug development, and the future of microbiome therapeutics.

    Dr Silberg is the Chief Scientific Officer at Beyond Celiac, a former global clinical leader at Shire/Takeda and AstraZeneca, and one of the most respected figures in GI medicine and microbiome science.

    In this episode, we explore:
    • How she moved from basic science to medicine to pharma leadership
    • Why the GI field needed so much research — and how it transformed
    • The real science behind ulcers, H. pylori, and the Barry Marshall story
    • What she teaches in her popular “Understanding Your Gut” course
    • Prebiotics vs probiotics — what actually matters
    • The truth about gluten, celiac disease, gluten sensitivity and rising incidence
    • The microbiome’s role in inflammation, autoimmune disease, mental health & IBS
    • Whether microbiome drug development is finally turning a corner
    • Why the gut–brain axis may be the most exciting frontier in medicine

    Dr Silberg also shares insights from her work with Finch Therapeutics, her role at Beyond Celiac, and her experience advising the team at Biotics.

    If you’re interested in gut science, the microbiome, diet, or how modern medicines are built from the ground up, you’ll get a huge amount from this conversation.

    Be well, trust your gut — and thanks for listening.

    00:00 Introduction to Dr Debra Silberg

    00:54 Dr Silberg's Career Journey

    02:26 Insights on Gut Health and Microbiome

    04:05 Understanding GI Diseases and Treatments

    07:41 The Role of Diet in Gut Health

    15:59 Celiac Disease and Gluten Sensitivity

    25:04 Exploring the Microbiome

    27:43 Exploring Therapeutic Approaches to the Microbiota

    31:36 Challenges in Microbiome Drug Development

    34:22 The Gut-Brain Connection and Mental Health

    39:13 Transitioning from Academia to Pharma

    41:45 Insights into Drug Development and Success Stories

    44:55 The Long Journey of Drug Development

    52:01 The Role of AI in FDA Reviews

    55:04 Quick Fire Round: Future of Microbiome Research

    You must not rely on the information in this video as an alternative to medical advice from your doctor or other professional healthcare provider. If you have any specific questions about any medical matter you should consult your doctor or other professional healthcare provider. If you think you may be suffering from any medical condition you should seek immediate medical attention. You should never delay seeking medical advice, disregard medical advice, or discontinue medical treatment because of the information in this video.
  • Inside Matters

    Unlocking Gut Health: FMT, MicroRNAs, and the Future with Dr Tanya Mongan

    20/11/2025 | 1h 10 mins.
    In this episode, Dr James McIlroy chats with Dr Tanya Mongan, clinical associate professor and gastroenterology consultant at the University of Nottingham. Dr Mongan specialises in gut health, particularly the gut–brain connection and faecal microbiota transplantation (FMT).

    She talks us through the current state of FMT, why it works so well, and how it’s becoming an increasingly important treatment for conditions like inflammatory bowel disease. We also explore her cutting-edge research into microRNA-based medicines—a new field examining tiny molecules that can help protect the gut and may one day be used to treat conditions linked to an unhealthy microbiome, including cystic fibrosis and neurodegenerative diseases.

    This episode breaks down the complexities of the microbiome in an easy-to-understand way, covering everything from the limits of current testing to the promise of personalised gut treatments. Dr Mongan also shares insights into exciting new tools such as organ-on-chip models, nano-delivery systems for microRNAs, and even zebrafish models used in gut research.

    If you want to understand where gut science is heading, what’s real and what’s hype, and how future therapies may become more precise and personalised, this is a must-listen.

    Chapter Markers

    00:00 Introduction to Dr Tanya Mongan and gut health
    01:51 Has the microbiome “bubble” burst?
    03:45 The big challenges in microbiome science
    06:13 What the future of microbiome testing could look like
    12:45 Understanding faecal microbiota transplantation (FMT)
    19:22 How FMT works and what current research shows
    26:29 Why the microbiome is so complex
    34:57 MicroRNAs: a new frontier in gut health
    37:41 Where microRNAs come from
    38:18 How microRNAs help protect the gut
    39:00 Why delivering microRNAs is difficult
    39:19 Nano-formulation: new ways to deliver microRNAs
    40:37 The advantages of organ-on-chip models
    42:02 Personalised “gut avatars”
    43:58 Zebrafish and other models used in gut research
    49:27 Clinical applications and future directions
    53:17 Microbiome therapy and FMT in clinical practice
    56:57 The future of microbiome research and treatment
    01:01:23 Diet, supplements, and the microbiome
    01:04:34 Weight-loss drugs and how they affect the microbiome
    01:07:52 Fascinating facts about the microbiome
    01:09:24 Final thoughts and wrap-up
  • Inside Matters

    Fatty Liver, Gut Health, and Functional Medicine - Dr Guy Neff

    06/11/2025 | 1h 10 mins.
    Revolutionising Liver Health: The Link Between Gut Health, Genetics, and Lifestyle

    In this episode, we dive deep into the intricate connections between liver health, gut health, genetic predispositions, and lifestyle factors. Our guest, Gary, a seasoned physician and entrepreneur, shares his extensive experience from pioneering liver disease research in the 90s to running a successful metabolic clinic focused on functional medicine today. Learn about the evolution of understanding fatty liver diseases like NASH and MASH, the impact of processed foods, and the groundbreaking treatments emerging, including the promising effects of GLP-1 therapies. Gary also discusses the pivotal role of a clean diet, exercise, and quality sleep in managing liver health, and the challenges of implementing these changes in a clinical setting. Don't miss this insightful conversation packed with practical advice and forward-thinking approaches to improving liver and overall metabolic health.

    00:00 The State of Food Quality in America vs Scotland
    02:39 Understanding Fatty Liver Disease: Past and Present
    05:29 Genetic and Environmental Factors in Fatty Liver Disease
    08:13 The Evolution of MASH: From NASH to Metabolic Health
    10:46 Emerging Treatments and Medications for Liver Disease
    13:35 The Role of GLP-1s in Managing Liver Health
    16:18 The Gut–Liver Connection: A Historical Perspective
    19:07 Building a Successful Liver Clinic: Insights and Challenges
    33:52 Understanding Metabolic Health and Genetic Testing
    35:13 The Importance of Gut Health
    37:39 Transforming Workplace Wellness Initiatives
    45:48 The Future of Functional Medicine
    51:30 Addressing Liver Health and Alcohol Consumption

    Takeaways

    The quality of food in America is declining, impacting health.

    Fatty liver disease is increasingly common, especially among those with higher body mass indexes.

    Genetic predisposition plays a significant role in liver disease.

    MASH is a critical condition that combines fatty liver with inflammation.

    Advancements in GLP-1 medications show promise for treating liver disease.

    Gut health is essential for overall wellness and liver health.

    Guy Neff's journey reflects a blend of medicine and business acumen.

    Building a successful liver clinic requires navigating numerous challenges.

    Functional medicine is gaining traction as a holistic approach to health.

    Routine testing for liver health is crucial for early detection and intervention.

    You must not rely on the information in this video as an alternative to medical advice from your doctor or other professional healthcare provider. If you have any specific questions about any medical matter you should consult your doctor or other professional healthcare provider. If you think you may be suffering from any medical condition you should seek immediate medical attention. You should never delay seeking medical advice, disregard medical advice, or discontinue medical treatment because of the information in this podcast.
  • Inside Matters

    Decoding the Microbiome: Genetic Discoveries with Dr. Ran Blekhman

    26/06/2025 | 1h 5 mins.
    In this episode, Dr. James McIlroy interviews Dr. Ran Blekhman, an associate professor at the University of Chicago, about the microbiome and its role as 'our second genome.'

    Dr. Blekhman shares his research findings on the genetic and environmental factors that shape the microbiome, the heritability of microbial genes, and the relationship between the human genome and microbiome. They also discuss Dr. Blekhman's groundbreaking research that analysed over 168,000 samples to understand global microbiome patterns, the influence of early-life microbiome development, and the potential of microbiome-based diagnostics and therapeutics. Tune in for a comprehensive dive into one of the most promising areas of genetic and microbial research.

    00:00 Introduction to Dr. R Blackman and the Microbiome
    01:23 Podcast Growth and Listener Engagement
    01:56 Starting the Conversation with Dr. Blackman
    02:04 Exploring the Second Genome
    02:24 Human Genome vs. Microbiome
    03:23 Genetic Interactions with the Microbiome
    04:02 Understanding Microbial Genes and Functions
    05:40 Heritability and Environmental Factors
    06:53 Microbiome Diversity and Heritability
    08:57 Research on Microbiome Heritability
    17:18 Baboon Model System for Microbiome Studies
    18:56 Population Scale Microbiome Research
    25:27 Global Patterns and Data Integration
    33:36 The Untapped Potential of Microbiome Data
    35:08 Hypotheses and Discoveries in Microbiome Research
    36:46 Geographical Variations in Microbiome
    49:18 Technical Challenges and Methodologies
    52:20 AI and Machine Learning in Microbiome Studies
    54:59 Future Directions and Clinical Applications
    01:00:38 Exploring Early Life Microbiome
    01:03:30 Conclusion and Further Reading
More Health & Wellness podcasts
About Inside Matters
The gut health show – conversations with the most forward-thinking minds in health, fitness, science, nutrition and business. In-depth discussions about how our gut microbiome impacts our health, well-being, mood and more.Inside Matters was conceived by microbiome expert Dr James McIlroy as a platform to raise awareness of the importance of the gut microbiome. Our aim is to inspire and educate listeners around the world about the importance of gut health, equipping them with the knowledge they need to transform their lives for the better. Produced by the Podcast Studio Glasgow.
Podcast website

Listen to Inside Matters, Feel Better, Live More with Dr Rangan Chatterjee and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features